Should you get a new COVID-19 booster? If so, when?
Here's what you should know about the new COVID-19 boosters. Should you get one? What if you just had COVID? We answer some common questions.
Q: How are the new boosters different?
Answer: They're combination or "bivalent" shots that contain half the original vaccine that's been used since December 2020 and half protection against today's dominant omicron versions, BA.4 and BA.5. It's the first update to COVID-19 vaccines ever cleared by the Food and Drug Administration.
Q: Who's eligible?
Answer: Updated shots made by Pfizer and its partner BioNTech are authorized for anyone 12 and older, and rival Moderna's version is for adults. They're to be used as a booster for anyone who's already had their primary vaccination series -- using shots from any U.S.-cleared company -- and regardless of how many boosters they've already gotten.
Q: If I just got one of the original boosters, should I get the new kind right away?
Answer: No. The FDA set the minimum wait time at two months. But advisers to the Centers for Disease Control and Prevention said it's better to wait longer. Some advise at least three months, another said someone who's not at high risk might wait as long as six months.
"If you wait a little more time, you get a better immunologic response," said CDC adviser Dr. Sarah Long of Drexel University.
That's because someone who recently got a booster already has more virus-fighting antibodies in their bloodstream. Antibodies gradually wane over time, and another shot too soon won't offer much extra benefit, explained Wherry, who wasn't involved with the government's decision-making.
Q: What if I recently recovered from COVID-19?
Answer: It's still important to get vaccinated even if you've already been infected -- but timing matters here, too.
The CDC has long told people to defer vaccination until they've recovered but also that people may consider waiting for three months after recovering to get a vaccination. And several CDC advisers say waiting the three months is important, both for potentially more benefit from the shot and to reduce chances of a rare side effect, heart inflammation, that sometimes affects teen boys and young men.
Q: How much benefit will the new boosters offer?
Answer: That's not clear, because tests of this exact recipe have only just begun in people.
The FDA cleared the new boosters based in large part on human studies of a similarly tweaked vaccine that's just been recommended by regulators in Europe. Those tweaked shots target an earlier omicron strain, BA.1, that circulated last winter, and studies found they revved up people's virus-fighting antibodies.
With that earlier omicron version now replaced by BA.4 and BA.5, the FDA ordered an additional tweak to the shots — and tests in mice showed they spark an equally good immune response.
There's no way to know if antibodies produced by an omicron-matched booster might last longer than a few months. But a booster also is supposed to strengthen immune system memory, adding to protection against serious illness from the ever-mutating virus.
Q: How do we know they're safe?
Answer: The basic ingredients used in both omicron-targeting updated vaccines are the same. Testing by Pfizer and Moderna of their BA.1-targeted versions proved safe in human studies and CDC's advisers concluded the additional small recipe change should be no different.
Flu vaccines are updated every year without human trials.
Q: Can I get a new COVID-19 booster and a flu shot at the same time?
Answer: Yes, one in each arm.
From the top 50 names for Baby Boomers and slang that defines the Millennial generation, to the unveiling of the Obama White House portraits, …
The flu shot is a familiar October ritual like football, foliage and Halloween, and health officials are also urging people to get a COVID booster.
President Biden’s suggestion the COVID-19 pandemic is over led to a backlash among some who say the comment is premature — and counterproductive.
Teams of scientists worldwide are racing to stay ahead of the next coronavirus by developing what's known as pan-coronavirus vaccines.
Imagine a time when your virus-blocking face covering is like an umbrella. Most days, it stays in your closet or is stowed somewhere in your car. But when a COVID-19 outbreak is in the forecast, you can put it to use. A group of would-be forecasters says it’s got the makings for such a system.
The Food and Drug Administration has withdrawn its provisional support for the use of Evusheld, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19.
